203 related articles for article (PubMed ID: 11535509)
1. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.
Diz-Küçükkaya R; Hacihanefioğlu A; Yenerel M; Turgut M; Keskin H; Nalçaci M; Inanç M
Blood; 2001 Sep; 98(6):1760-4. PubMed ID: 11535509
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura.
Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Olivieri M; Zaccari G; Gandolfo GM; Galli M
Blood; 1994 Dec; 84(12):4203-8. PubMed ID: 7994034
[TBL] [Abstract][Full Text] [Related]
3. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
[TBL] [Abstract][Full Text] [Related]
4. Lupus anticoagulant in immune thrombocytopenic purpura.
Dash S; Marwaha RK; Mohanty S
Indian J Pediatr; 2004 Jun; 71(6):505-7. PubMed ID: 15226559
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia.
Yang YJ; Yun GW; Song IC; Baek SW; Lee KS; Ryu HW; Lee MW; Lee HJ; Yun HJ; Kim S; Jo DY
Korean J Intern Med; 2011 Dec; 26(4):449-54. PubMed ID: 22205846
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B
Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681
[TBL] [Abstract][Full Text] [Related]
8. Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study.
Frison L; Lombardi A; Caputo I; Semenzato G; Fabris F; Vianello F
Hematology; 2019 Dec; 24(1):134-138. PubMed ID: 30355275
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
10. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
11. Antibody profiles for the diagnosis of antiphospholipid syndrome.
Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
Dayama A; Dass J; Mahapatra M; Saxena R
Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
[TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid syndrome diagnosis: an update].
Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
[TBL] [Abstract][Full Text] [Related]
15. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Matsubara K; Morioka T; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Intern Med; 2016; 55(6):589-95. PubMed ID: 26984073
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
17. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.
Bertolaccini ML; Roch B; Amengual O; Atsumi T; Khamashta MA; Hughes GR
Br J Rheumatol; 1998 Nov; 37(11):1229-32. PubMed ID: 9851275
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
20. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]